Earnings call BioNTech delivered EUR 2.9 billion in 2025 revenue, surpassing guidance despite declining COVID-19 vaccine sales, aided by BMS collaboration payments. 2026 guidance targets EUR 2.0–2.3 ...
Why Bristol-Myers Squibb (BMY) is on investors’ radar today Bristol-Myers Squibb (BMY) continues to attract attention as a large US biopharmaceutical group with exposure to oncology, hematology and ...
Personal and small business cards issued by Bank of America are currently not available on CNBC Select, and links have been redirected to our credit card marketplace, where you can review offers from ...
The Range's Two-Tier Console Table With Steel Frame Hallway Furniture is available to order online with free home delivery for £49.99 in a selection of colours. The brown wooden version is almost ...
CAMBRIDGE, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today ...
Renovating water heating alone can provide some middle ground between ongoing maintenance of outdated systems and costly large-scale building refurbishment. The obvious choice if renovating a building ...
When you buy an EV, you expect a few changes over time. Tires wear, software updates arrive, and the battery slowly loses a ...
BioNTech SE is transitioning from a COVID-19 vaccine story to a late-stage oncology platform with a robust $17B cash position. Click to read why BNTX is a Buy.
Bristol Myers Squibb is part of the biopharmaceutical sector, a segment defined by research driven drug development, global ...
DONGGUAN, GUANGDONG, CHINA, March 10, 2026 /EINPresswire.com/ -- The World New Energy Vehicle and Smart Mobility Show ...
Between tech giants and coal companies, the new rules of blue-chip investing might look different to the past.
When future generations look back upon the Great Derangement, they will certainly blame the leaders and politicians of this time for their failure to address the climate crisis. But they may well hold ...